CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND AEGERION PHARMACEUTICALS, INC.Corporate Integrity Agreement • September 22nd, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations
SETTLEMENT AGREEMENTSettlement Agreement • September 22nd, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations
This Settlement Agreement (“Agreement”) is entered into among the following Parties (“Parties”): the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”); the Defense Health Agency (“DHA”), acting on behalf of the TRICARE Program (collectively, the “United States”); Aegerion Pharmaceuticals, Inc. (“Aegerion”); and Michele Clark, Tricia Mullins, and Kristi Winger Szudlo (collectively, “Relators”), through their authorized representatives.
